BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 34986361)

  • 1. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
    Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
    Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
    ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of the Lipoprotein(a) to Prealbumin Ratio and of the NT-proBNP to LVEF Ratio for Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
    Zhang Y; Shi F
    Heart Surg Forum; 2023 Oct; 26(5):E470-E477. PubMed ID: 37920075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS.
    Wang JL; Guo CY; Chen H; Li HW; Zhao XQ; Zhao SM
    BMC Cardiovasc Disord; 2021 Mar; 21(1):122. PubMed ID: 33663377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
    BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention: CCC-ACS Project Analysis.
    Zhao X; Ai G; Qiu M; Wang X; Zhang L; Yang X; Liu Y; Xu P; Zhang J; Gu C; Zhou M; Hao Y; Zhao D; Han Y;
    Int J Cardiol; 2020 Jul; 310():1-8. PubMed ID: 32307186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
    Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of NT-proBNP on admission on left ventricular ejection fraction and in-patients major adverse cardiac and cerebrovascular events in hospitalized patients with unstable angina].
    Gao XY; Chen H; Ding XS; Wu SS; Wei W; Li HW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):117-122. PubMed ID: 30818939
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
    Scirica BM; Sabatine MS; Jarolim P; Murphy SA; de Lemos JL; Braunwald E; Morrow DA
    Eur Heart J; 2011 Mar; 32(6):697-705. PubMed ID: 21183500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.
    Liu HY; Wang W; Shi DZ; Ge JB; Zhang L; Peng J; Wang CL; Wang PL
    Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor of Clinical Outcomes in CAD Patients After PCI.
    Fan L; Zhang ZL; Tang JN; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Yue XT; Bai Y; Dai XY; Zheng RJ; Zheng YY; Zhang JY
    Clin Appl Thromb Hemost; 2022; 28():10760296221113345. PubMed ID: 35903893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA
    Mu X; Qiu M; Li Y; Li Z; Qi B; Jing Z; Jing Q
    Clin Cardiol; 2023 Jul; 46(7):810-817. PubMed ID: 37218400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
    Pan R
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of early phrase echocardiography and cardiac biological markers in patients with severe sepsis: a five-year single-center retrospective study].
    Zang X; Chen W; Sheng B; Zhao L; Gu X; Zhen J; Liu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):332-336. PubMed ID: 29663994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes.
    Manenti ER; Bodanese LC; Camey SA; Polanczyk CA
    Clin Cardiol; 2006 Sep; 29(9):405-10. PubMed ID: 17007172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.